Nhung Truong Thi Thuy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nhung Truong Thi Thuy has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Dao Cuong To
Phenikaa University Nano Institute, Phenikaa School of Engineering, Phenikaa University, Nguyen Trac, Duong Noi, Hanoi 12116, Vietnam
5 shared publications - Phi-Hung Nguyen
Institute of Chemistry, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Nghia Do, Hanoi 122100, Vietnam
4 shared publications - Hoa Thi Nguyen
Phenikaa University Nano Institute (PHENA), Phenikaa School of Engineering (PSE), Phenikaa University, Hanoi, Vietnam
3 shared publications - Le Minh Hoang
Phenikaa University Nano Institute, Phenikaa University, Ha Dong, Vietnam
3 shared publications Truong Thi Viet Hoa
Phenikaa University Nano Institute (PHENA), Phenikaa University, Hanoi, Vietnam
3 shared publicationsHoa Thi Nguyen
Phenikaa University Nano Institute (PHENA), Phenikaa University, Hanoi, Vietnam
2 shared publications
Latest Publications
- Open Access
- 1 September 2024
- Published by SAGE Publications in Journal of Chemical Research
- Vol. 48 (5)
Anti-lipase activity from Polygonum multiflorum: An in vitro and in silico study
A study on the phytochemical composition of the roots of Polygonum multiflorum collecting in Vietnam and an evaluation of its capacity to inhibit pancreatic lipase enzyme was conducted. In total, 12 metabolites (1–12) were isolated from anti-lipase activity-guided fractionation of P. multiflorum. The isolated compounds (1–12) were identified as trans-resveratrol (1), methyl protocatechuate (2), methyl gallate (3), catechin (4), epicatechin (5), myrciaphenone A (6), quercetin (7), kaempferol (8), apigenin (9), luteolin (10), tricin (11), and afzelin (12). This is the first time Compound 12 has been reported from P. multiflorum. However, 12 second metabolites (1–12) were tested in vitro to assess the anti-lipase potential. The results revealed Compound 7 exhibited the most significant lipase inhibition, with an IC50 value of 0.30 ± 0.04 μM. Following closely, Compounds 6, 8, 10, and 12 displayed IC50 values of 5.38 ± 0.65, 0.72 ± 0.10, 0.79 ± 0.19, and 1.22 ± 0.18 μM, respectively. For comparison, orlistat (positive control), the most common anti-obesity drug available on the market, has an IC50 value of 0.91 ± 0.10 μM. Molecular docking was applied to explore the affinity and interactions between active compounds 6–8, 10, and 12 and proteins associated with obesity, namely pancreatic lipase–colipase complex (PLCC) and pancreatic lipase-related protein 1 (PLRP1). In addition, absorption, distribution, metabolism, excretion, and toxicity (ADMET) were used in predictions. The results indicate that the active compounds isolated from P. multiflorum could be further in-depth research on lipase inhibition.
- 1 September 2024
- Published by SAGE Publications in Journal of Chemical Research
- Vol. 48 (5)
Open AccessAnti-lipase activity from Polygonum multiflorum: An in vitro and in silico study
A study on the phytochemical composition of the roots of Polygonum multiflorum collecting in Vietnam and an evaluation of its capacity to inhibit pancreatic lipase enzyme was conducted. In total, 12 metabolites (1–12) were isolated from anti-lipase activity-guided fractionation of P. multiflorum. The isolated compounds (1–12) were identified as trans-resveratrol (1), methyl protocatechuate (2), methyl gallate (3), catechin (4), epicatechin (5), myrciaphenone A (6), quercetin (7), kaempferol (8), apigenin (9), luteolin (10), tricin (11), and afzelin (12). This is the first time Compound 12 has been reported from P. multiflorum. However, 12 second metabolites (1–12) were tested in vitro to assess the anti-lipase potential. The results revealed Compound 7 exhibited the most significant lipase inhibition, with an IC50 value of 0.30 ± 0.04 μM. Following closely, Compounds 6, 8, 10, and 12 displayed IC50 values of 5.38 ± 0.65, 0.72 ± 0.10, 0.79 ± 0.19, and 1.22 ± 0.18 μM, respectively. For comparison, orlistat (positive control), the most common anti-obesity drug available on the market, has an IC50 value of 0.91 ± 0.10 μM. Molecular docking was applied to explore the affinity and interactions between active compounds 6–8, 10, and 12 and proteins associated with obesity, namely pancreatic lipase–colipase complex (PLCC) and pancreatic lipase-related protein 1 (PLRP1). In addition, absorption, distribution, metabolism, excretion, and toxicity (ADMET) were used in predictions. The results indicate that the active compounds isolated from P. multiflorum could be further in-depth research on lipase inhibition.
- Open Access
- 1 July 2024
- Published by SAGE Publications in Journal of Chemical Research
- Vol. 48 (4)
Nitric oxide production inhibitors from Vietnamese Scutellaria indica: An in vitro and in silico study
Seven metabolites (1–7) were isolated from the Vietnamese Scutellaria indica, guided by anti-inflammatory activity. The identified compounds comprise scrocaffeside A (1), naringenin-7-O-glucoside (2), darendoside B (3), decaffeoylverbascoside (4), plantainoside C (5), acteoside (6), and isoacteoside (7). This is the first time the compounds 1–3 and 5 were isolated from the entire Scutellaria indica. Compounds 1–7 tested for their anti-inflammatory potential by inhibiting nitric oxide (NO) production. Compound 1 showed the most activity (IC50 = 31.4 μM), followed by compounds 2, 4, 6, and 7 exhibited IC50 values of 41.2, 87.4, 52.2, and 44.6 μM, respectively. However, compounds 3 and 5 were inactive (IC50 > 100 μM). Molecular docking was applied to study the affinity and interactions between compound 1 and inflammatory-caused proteins based on the in vitro results. Compound 1 generated the lowest binding free energy with the cyclooxygenase-2 (COX-2) target, which was −9.8 kcal/mol, followed by inducible nitric oxide synthase (iNOS, –8.4 kcal/mol), and interleukin-8 (IL-8, –7.6 kcal/mol). The results indicate that compound 1 derived from S. indica has the potential to be further explored and developed as an inflammatory inhibitor.
- 1 July 2024
- Published by SAGE Publications in Journal of Chemical Research
- Vol. 48 (4)
Open AccessNitric oxide production inhibitors from Vietnamese Scutellaria indica: An in vitro and in silico study
Seven metabolites (1–7) were isolated from the Vietnamese Scutellaria indica, guided by anti-inflammatory activity. The identified compounds comprise scrocaffeside A (1), naringenin-7-O-glucoside (2), darendoside B (3), decaffeoylverbascoside (4), plantainoside C (5), acteoside (6), and isoacteoside (7). This is the first time the compounds 1–3 and 5 were isolated from the entire Scutellaria indica. Compounds 1–7 tested for their anti-inflammatory potential by inhibiting nitric oxide (NO) production. Compound 1 showed the most activity (IC50 = 31.4 μM), followed by compounds 2, 4, 6, and 7 exhibited IC50 values of 41.2, 87.4, 52.2, and 44.6 μM, respectively. However, compounds 3 and 5 were inactive (IC50 > 100 μM). Molecular docking was applied to study the affinity and interactions between compound 1 and inflammatory-caused proteins based on the in vitro results. Compound 1 generated the lowest binding free energy with the cyclooxygenase-2 (COX-2) target, which was −9.8 kcal/mol, followed by inducible nitric oxide synthase (iNOS, –8.4 kcal/mol), and interleukin-8 (IL-8, –7.6 kcal/mol). The results indicate that compound 1 derived from S. indica has the potential to be further explored and developed as an inflammatory inhibitor.
- Open Access
- 1 July 2024
- Published by SAGE Publications in Journal of Chemical Research
- Vol. 48 (4)
In silico molecular docking, DFT, and toxicity studies of potential inhibitors derived from Millettia dielsiana against human inducible nitric oxide synthase
Inducible nitric oxide synthase is known as a potential biological target that plays a crucial role in regulating the release of nitric oxide and is responsible for the amount of nitric oxide released during the inflammation process. Searching for compounds from natural sources that inhibit inducible nitric oxide synthase may reduce excessive nitric oxide production and counteract metabolic diseases originating from prolonged inflammation. One of the valuable medicinal plants with significant anti-inflammatory activity evaluated in this study is Millettia dielsiana. The current work focuses on the molecular docking analysis of compounds derived from Millettia dielsiana to identify potential candidates against the inducible nitric oxide synthase enzyme. As a result, four compounds (D10 (Tupichinol C), D20 (Durmillone), D46 (Glycitin), and D50 (5,7,4′-trihydroxyisoflavone 7- O-β-d-apiofuranosyl-(1→6)-β-d-glucopyranoside) with the most potent inhibitory potential were identified with binding affinities less than −9.0 kcal mol−1. Moreover, toxicity predictions using the ProTox II web server indicated that these compounds exhibit low toxicity (Toxicity Class of 5). Compound D50 showed no activity in hepatotoxicity, carcinogenicity, immunotoxicity, mutagenicity, and cytotoxicity. Density functional theory was employed for molecular description, electronic properties, and chemical reactivity of the compounds. These findings provide a basis for further in-depth biological experiments in the future.
- 1 July 2024
- Published by SAGE Publications in Journal of Chemical Research
- Vol. 48 (4)
Open AccessIn silico molecular docking, DFT, and toxicity studies of potential inhibitors derived from Millettia dielsiana against human inducible nitric oxide synthase
Inducible nitric oxide synthase is known as a potential biological target that plays a crucial role in regulating the release of nitric oxide and is responsible for the amount of nitric oxide released during the inflammation process. Searching for compounds from natural sources that inhibit inducible nitric oxide synthase may reduce excessive nitric oxide production and counteract metabolic diseases originating from prolonged inflammation. One of the valuable medicinal plants with significant anti-inflammatory activity evaluated in this study is Millettia dielsiana. The current work focuses on the molecular docking analysis of compounds derived from Millettia dielsiana to identify potential candidates against the inducible nitric oxide synthase enzyme. As a result, four compounds (D10 (Tupichinol C), D20 (Durmillone), D46 (Glycitin), and D50 (5,7,4′-trihydroxyisoflavone 7- O-β-d-apiofuranosyl-(1→6)-β-d-glucopyranoside) with the most potent inhibitory potential were identified with binding affinities less than −9.0 kcal mol−1. Moreover, toxicity predictions using the ProTox II web server indicated that these compounds exhibit low toxicity (Toxicity Class of 5). Compound D50 showed no activity in hepatotoxicity, carcinogenicity, immunotoxicity, mutagenicity, and cytotoxicity. Density functional theory was employed for molecular description, electronic properties, and chemical reactivity of the compounds. These findings provide a basis for further in-depth biological experiments in the future.
- 23 May 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (5) , 1177-1184
Inhibitors of Nitric Oxide Production from the Seeds of Myristica fragrans: Experimental and Computational Results
- 23 May 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (5) , 1177-1184
Inhibitors of Nitric Oxide Production from the Seeds of Myristica fragrans: Experimental and Computational Results
- 16 January 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (3) , 666-672
Nitric Oxide Inhibitors from the Stem Bark of Biancaea decapetala: An In Vitro and In Silico Study
- 16 January 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (3) , 666-672
Nitric Oxide Inhibitors from the Stem Bark of Biancaea decapetala: An In Vitro and In Silico Study
- Open Access
- 22 October 2023
- Published by Elsevier in Data in Brief
- Vol. 51, 109713
Dataset on the compounds from the leaves of Vietnamese Machilus thunbergii and their anti-inflammatory activity
- 22 October 2023
- Published by Elsevier in Data in Brief
- Vol. 51, 109713
Open AccessDataset on the compounds from the leaves of Vietnamese Machilus thunbergii and their anti-inflammatory activity